X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (735) 735
Publication (60) 60
Book Review (24) 24
Book Chapter (21) 21
Book / eBook (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (518) 518
oncology (458) 458
index medicus (390) 390
female (253) 253
cancer (222) 222
chemotherapy (207) 207
male (206) 206
middle aged (172) 172
adult (163) 163
aged (146) 146
animals (128) 128
treatment outcome (126) 126
advanced solid tumors (124) 124
sarcoma (120) 120
neoplasms - drug therapy (112) 112
pharmacology & pharmacy (102) 102
tumors (101) 101
soft-tissue sarcomas (95) 95
care and treatment (91) 91
advanced breast-cancer (87) 87
soft-tissue sarcoma (87) 87
sarcoma - drug therapy (86) 86
phase-ii trial (84) 84
antineoplastic agents - therapeutic use (83) 83
antineoplastic combined chemotherapy protocols - therapeutic use (82) 82
metastasis (79) 79
research (78) 78
cell lung-cancer (76) 76
clinical trials (71) 71
radiology, nuclear medicine & medical imaging (70) 70
radiotherapy (68) 68
cancer therapies (67) 67
soft tissue sarcoma (67) 67
health aspects (66) 66
prognosis (63) 63
review (62) 62
doxorubicin (59) 59
drug therapy (57) 57
surgery (57) 57
adolescent (56) 56
renal-cell carcinoma (54) 54
advanced cancer (53) 53
ifosfamide (52) 52
clinical trials as topic (51) 51
patients (51) 51
phase-i (50) 50
phase-ii (50) 50
squamous-cell carcinoma (50) 50
angiogenesis (48) 48
disease-free survival (48) 48
medicine & public health (47) 47
sarcoma - pathology (47) 47
solid tumors (47) 47
aged, 80 and over (46) 46
antineoplastic agents - pharmacology (46) 46
antineoplastic agents - adverse effects (45) 45
retrospective studies (45) 45
hematology (44) 44
hypoxia (44) 44
therapy (43) 43
endothelial growth-factor (42) 42
neoplasms - metabolism (42) 42
combined modality therapy (41) 41
article (40) 40
medicine (40) 40
positron-emission-tomography (40) 40
trial (40) 40
child (39) 39
double-blind (39) 39
young adult (39) 39
hematology, oncology and palliative medicine (38) 38
neoplasms - pathology (38) 38
survival (38) 38
analysis (37) 37
antineoplastic agents (37) 37
radiation therapy (37) 37
antineoplastic combined chemotherapy protocols - adverse effects (36) 36
studies (36) 36
advanced hepatocellular-carcinoma (35) 35
advanced soft-tissue (35) 35
neck-cancer (35) 35
breast-cancer (34) 34
cancer research (33) 33
cell biology (33) 33
european-organization (33) 33
gemcitabine (33) 33
neoplasm staging (33) 33
neoplasms. tumors. oncology. including cancer and carcinogens (33) 33
survival rate (33) 33
advanced basic science (32) 32
advanced soft tissue sarcoma (32) 32
antimitotic agents (32) 32
open-label (32) 32
medicine, research & experimental (31) 31
usage (31) 31
1st-line treatment (30) 30
antineoplastic agents - administration & dosage (30) 30
medical research (30) 30
metastatic colorectal-cancer (30) 30
mice (30) 30
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (737) 737
German (8) 8
French (7) 7
Chinese (1) 1
Czech (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 08/2014, Volume 120, Issue 16, pp. 2448 - 2456
Journal Article
Journal Article
Surgical Clinics of North America, ISSN 0039-6109, 10/2016, Volume 96, Issue 5, pp. 1141 - 1156
Journal Article
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 07/2017, Volume 10, Issue 7, pp. 699 - 705
Journal Article
Cancer, ISSN 0008-543X, 01/2011, Volume 117, Issue 2, pp. 372 - 379
BACKGROUND: The objective of this study was to assess patient, tumor, and treatment factors that affected overall survival in a group of patients who underwent... 
metastases | sarcoma | lymph nodes | palliative | radiotherapy | chemotherapy | surgery | SURVIVAL | ADVANCED CANCER | DOSE DOXORUBICIN | PHASE-III | TRIAL | DOXORUBICIN PLUS IFOSFAMIDE | LYMPH-NODE METASTASIS | ONCOLOGY | EXTREMITY | EUROPEAN-ORGANIZATION
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2018, Volume 103, pp. 88 - 97
LY3039478 is an orally bioavailable selective Notch inhibitor. This phase 1a/b trial evaluated the safety, pharmacokinetics and antitumour activity of... 
Pleomorphic sarcoma | Gastrointestinal stromal tumours | Leiomyosarcoma | Rhabdomyosarcoma | Liposarcoma | Soft tissue sarcoma | Notch inhibitor | Angiosarcoma | CRITERIA | GAMMA-SECRETASE INHIBITOR | ADVANCED SOLID TUMORS | RECIST | CANCER | RO4929097 | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | PHASE-I | Sarcoma | Development and progression | Index Medicus
Journal Article
BMC CANCER, ISSN 1471-2407, 08/2019, Volume 19, Issue 1, pp. 794 - 7
Background PALETTE is a phase 3 trial that demonstrated single-agent activity of pazopanib in advanced soft tissue sarcomas (aSTS). We performed retrospective... 
Advanced soft tissue sarcoma | HETEROGENEITY | EVOLUTION | ONCOLOGY | PALETTE subgroup analysis | OLDER | Progression-free survival | ELDERLY-PATIENTS | Pazopanib | AGE
Journal Article
18.